We See More in NICU/PICU Cases
All genetic tests are not equal. With our whole genome platform we see more. More variants, with greater resolution, all with one sample – in 5 days or less.
A timely genetic diagnosis can be life saving
When there’s an acutely ill newborn or child in the NICU/PICU, time-sensitive medical management is imperative for ensuring the best outcome. Rapid whole genome testing can be an important tool in your medical arsenal as an accurate genetic diagnosis may:
- Identify disorders with specific targeted treatments
- Identify treatments to stop or avoid
- Identify eligible clinical trials
- Reduce the need for additional, invasive testing
- Inform family planning
- Connect families with support networks
Many NICU patients benefit from genetic testing
Whole genome testing reveals more in every test
Genetic disorders are caused by a wide variety of DNA changes. Comprehensive detection of all major clinically relevant variant types requires the right technology. Which is why we use PCR-free whole genome sequencing (WGS) that generates uniform coverage of >98% of the patient’s DNA. Compare that to PCR-based panel and exome technologies that remove and skew data, generating fragmented coverage of only 1-2% of the patient’s DNA. Pairing WGS with our Genomic Intelligence® proprietary analytical software provides the most comprehensive variant detection available.
Variants detected by our Genomic Unity® Lightning Genome Analysis include:
More variants are revealed with greater resolution
Our whole genome platform has a detection range from 1bp to whole chromosomal events. Intronic and intergenic regions are always included. As a result, our testing identifies a wide range of variants missed by other panel and exome tests – including variants that you would typically expect to be detected. Explore our technical note and representative example case to learn more about why this is.